Poster Abstract Session:
52. Antimicrobial Stewardship: Special Populations
Thursday, October 4, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Pediatric ID, Investigative ID, Adult ID


Presentations:
245
Elimination of Routine Urinalysis Before Elective Orthopedic Surgery Reduces Antibiotic Utilization Without Impacting Catheter-Associated Urinary Tract Infection or Surgical Site Infection Rates
Megan Hoffman, (undergraduate); Kevin Counterman, BS; Sheila Querfurth, MSN, ANP-BC; Brian L. Hollenbeck, MD; Christine Bell, MSN, RN, CAPA, WCC
246
Posters
  • IDWeek_Mauro.pdf (337.4 kB)
  • 247
    Sustaining Excellence of Care During A Fluid Shortage: Snapshot of Antibiotic Mitigation Strategies Following Hurricane Maria
    Rachel V. Marini, PharmD; Brian A. Potoski, PharmD; William R. Wilson, PharmD; Bonnie Falcione, PharmD, BCPS AQ-ID; Lloyd Clarke, B Sc (Hons); Alfred L'Altrelli, PharmD; Tina Khadem, PharmD; Ryan K. Shields, PharmD; Cornelius J. Clancy, M.D.; M. Hong Nguyen, MD; Paige Gross, PharmD; J. Alexander Viehman, MD; Janine Then, PharmD
    Posters
  • Fluid Shortage.pdf (1.1 MB)
  • 248
    Antimicrobial Therapy for Suspected Urinary Tract Infection in Advanced Cancer Patients Transitioning to Comfort Measures
    Tianyun Wang, BS; Rupak Datta, MD PhD; Mojun Zhu, MD; Vincent Quagliarello, MD, FIDSA; Louise Marie Dembry, MD, MS, MBA, FSHEA; Manisha Juthani-Mehta, MD, FIDSA, FSHEA
    Posters
  • Poster_IDWeek_20180921_TW.pdf (313.9 kB)
  • 249
    Frequency of Antimicrobial Complications following Initiation of Palliative Chemotherapy in Advanced Cancer Patients
    Rupak Datta, MD PhD; Margaret Doyle, MPhil; Vincent Quagliarello, MD, FIDSA; Tara Sanft, MD; Manisha Juthani-Mehta, MD, FIDSA, FSHEA
    250
    Antimicrobial Management in Extracorporeal Membrane Oxygenation: The AMMO study
    Aditya Shah, MBBS; Prabij Dhungana, MBBS; Priya Sampathkumar, MD, FIDSA, FSHEA; John K. Bohman, MD; John C O'horo, MD
    252
    Relative use of carbapenems in immunocompromised patients
    Jacob Pierce, MD; Kimberly Lee, PharmD; John Markley, DO; Amy Pakyz, PharmD, MS, PhD; Michelle Doll, MD, MPH; Andrew Kirk, BS; Gonzalo Bearman, MD, MPH, FSHEA; Oveimar De La Cruz, MD; Michael Stevens, MD, MPH
    253
    Febrile Neutropenia Antibiotic De-escalation Study in Acute Myeloid Leukemia Patients with Prolonged Neutropenia
    William Alegria, PharmD; Bernard L. Marini, PharmD, BCOP; Anthony J. Perissinotti, PharmD, BCOP; Dale Bixby, MD; Kevin Gregg, MD; Jerod Nagel, PharmD, BCPS
    Posters
  • Alegria_IDWeek2018_1.pdf (329.8 kB)
  • 254
    Antimicrobial Use in Hospitalized Older Patients with Advanced Cancer
    Mojun Zhu, MD; Rupak Datta, MD PhD; Vincent Quagliarello, MD, FIDSA; Manisha Juthani-Mehta, MD, FIDSA, FSHEA
    255
    Evaluation of Antibiotic Prescribing at University-Affiliated Dental Clinics
    Emily Spivak, MD, MHS; James Winkler, DDS, PhD; Barbara Dixon, RDH, BS, MEd; Lilliam Pinzon, DDS, MS, MPH; Dania Al Dulaimi, BS; McKenna Nevers, MSPH; Michele Junger, DDS, MPH; Katherine Fleming-Dutra, MD; Karl Madaras-Kelly, PharmD., MPH; Matthew Samore, MD, FSHEA
    Posters
  • DentalPoster_9_24_18.pdf (736.6 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.